# The PIO (Propel In Office) III Study of In-office Placement of a Steroid-Eluting Implant Immediately Following Ethmoid Sinus Surgery

> **NCT02687438** · NA · COMPLETED · sponsor: **ENT and Allergy Associates, LLP** · enrollment: 20 (actual)

## Conditions studied

- Chronic Sinusitis

## Interventions

- **DEVICE:** Steroid-releasing sinus implant
- **OTHER:** Post-op standard of care

## Key facts

- **NCT ID:** NCT02687438
- **Lead sponsor:** ENT and Allergy Associates, LLP
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-11-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02687438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02687438, "The PIO (Propel In Office) III Study of In-office Placement of a Steroid-Eluting Implant Immediately Following Ethmoid Sinus Surgery". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02687438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*